Q1 2020 Alexion Pharmaceuticals Inc Earnings Call

6/5/2020 8:00

Conference Call Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc Conference call or earnings call will be held on May 6, 2020 via an 800 number (toll-free). During the earnings conference call's session Alexion Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Alexion Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a biopharmaceutical company focused on serving patients with devastating and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. In our complement franchise, Soliris is the first and only therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening and ultra-rare genetic blood disorder, or atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. PNH and aHUS are two severe and ultra-rare disorders resulting from chronic uncontrolled activation of the complement component of the immune system. 4 -------------------------------------------------------------------------------- In our metabolic franchise, we market Strensiq for the treatment of patients with Hypophosphatasia (HPP) and Kanuma for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D).    
Read more Conference Call

Alexion Pharmaceuticals Inc (ALXN)

100 College Street, New Haven Connecticut 06510, United States